In today’s briefing:
- Index Consultation on DATCos Means MORE Selling Likely, and Another Index Questionable
- EchoStar Offloads Spectrum to SpaceX—Is This the End of Its Wireless Ambitions?
- Cognex Corporation: Advancements and Penetration in the Logistics Sector & Key Growth Levers!
- Tyler Technologies: Its Efforts Towards Cross-Sell & Upsell Initiatives to Drive Higher Growth & Revenue Potential From Current Accounts!
- BlackLine Is A Takeover Target Again—And Investors Want It Gone!
- Bio-Rad Laboratories Just Supercharged Its PCR Portfolio—Is This a Game-Changer in Oncology?
- Avantor: Bioprocessing Innovation in Sterile Sampling & Other Key Growth Levers!
- Clean Harbors Is Banking on 600N Base Oil – Can This Bet Up The Ante?
- Bausch + Lomb Corporation’s Growth Surge: Can New Contact Lens Tech Grab A Larger Chunk Of The Market?
- CarMax CEO Walks Out, Earnings Tank—Wall Street Sounds The Alarm!
Index Consultation on DATCos Means MORE Selling Likely, and Another Index Questionable
- In mid-September, global index provider M _ _ _ announced that they were conducting an index consultation on Digital Asset Treasury Cos. I wrote about it here.
- My recommended short at the time is down 30%, despite announcing a large buyback program. Others have lost significant premium vs underlying digital assets.
- The same index provider expanded their list of affected names on 29 Oct. And a DIFFERENT Index provider this week added DATCOs to a US Advisory Panel Meeting Agenda Wednesday.
EchoStar Offloads Spectrum to SpaceX—Is This the End of Its Wireless Ambitions?
- EchoStar’s recently amended agreement to sell its unpaired AWS-3 spectrum licenses to SpaceX for $2.6 billion in SpaceX stock represents a pivotal shift in its operational and strategic trajectory.
- Building on a previous September deal where EchoStar committed to transferring AWS-4 and H-block licenses to SpaceX for up to $17 billion (half cash, half stock), this new AWS-3 transaction strengthens both firms’ long-term ambitions.
- For EchoStar, this move not only unlocks immediate financial runway and positions it to operate more flexibly but also furthers its transformation from a spectrum-heavy, capital-intensive business into a leaner, investment-focused entity.
Cognex Corporation: Advancements and Penetration in the Logistics Sector & Key Growth Levers!
- Cognex Corporation reported strong financial results for the third quarter of 2025, showcasing a solid strategic direction and improved operational efficiencies.
- The company’s focus on AI technology for industrial machine vision is evident in its performance and the introduction of innovative products like the SLX, aimed at enhancing logistics applications.
- Positive aspects from the results include achieving double-digit revenue growth and reaching the highest adjusted EBITDA margin since Q2 of 2023.
Tyler Technologies: Its Efforts Towards Cross-Sell & Upsell Initiatives to Drive Higher Growth & Revenue Potential From Current Accounts!
- Tyler Technologies reported strong third-quarter 2025 results, with revenues growing by nearly 10% year-over-year.
- This growth was driven by a 20% increase in SaaS revenue and an 11.5% rise in transaction revenue.
- The company has maintained a steady pipeline of business, supported by stable RFP and demo activities, suggesting a resilient demand in the public sector for Tyler’s solutions.
BlackLine Is A Takeover Target Again—And Investors Want It Gone!
- BlackLine, a leader in financial automation solutions, recently announced its Q1 2025 earnings results, highlighting both opportunities and challenges as the company navigates its ongoing journey towards growth and market expansion.
- The company reported a total revenue increase of 6% year-over-year, reaching $167 million, with strong subscription and services revenue performance.
- However, the financial results are a mix of positives and certain areas that might require attention.
Bio-Rad Laboratories Just Supercharged Its PCR Portfolio—Is This a Game-Changer in Oncology?
- Bio-Rad Laboratories’ financial performance for the third quarter of 2025 was characterized by modest revenue growth, constrained by headwinds in various segments.
- The company reported net sales of approximately $653 million, a slight increase from $650 million in the third quarter of 2024 on a reported basis but a 1.7% decrease on a currency-neutral basis.
- This outcome was primarily influenced by challenges in the academic research and biotech funding sectors, which impacted the Life Science segment.
Avantor: Bioprocessing Innovation in Sterile Sampling & Other Key Growth Levers!
- Avantor’s recent quarterly earnings report provides a mixed view of the company’s current performance and strategic outlook.
- Avantor experienced a 5% decline in quarterly revenue year-over-year, with reported revenue of $1.62 billion.
- The decline primarily affects the Laboratory Solutions and Bioscience Production segments.
Clean Harbors Is Banking on 600N Base Oil – Can This Bet Up The Ante?
- Clean Harbors reported its third-quarter 2025 results, which showcased a mixture of strengths and challenges, leaving investors with a nuanced investment thesis.
- The company’s performance was marked by a year-over-year growth in revenue and adjusted EBITDA, driven primarily by increased waste volumes and pricing gains across the network, although macroeconomic factors presented headwinds.
- Positively, Clean Harbors achieved a consolidated adjusted EBITDA margin improvement of 100 basis points, reaching 20.7%, a sign of effective pricing and cost-saving strategies.
Bausch + Lomb Corporation’s Growth Surge: Can New Contact Lens Tech Grab A Larger Chunk Of The Market?
- Bausch + Lomb recently held its third-quarter 2025 financial results presentation, highlighting several aspects of its performance and strategic focus.
- The company demonstrated notable growth across its various segments, driven by innovative product offerings and rigorous execution.
- Revenue for the quarter reached $1.281 billion, marking a 6% year-over-year increase.
CarMax CEO Walks Out, Earnings Tank—Wall Street Sounds The Alarm!
- CarMax’s second quarter results for fiscal year 2026 reveal a mixed performance in a challenging market.
- The company reported total sales of $6.6 billion, down 6% compared to the previous year, mainly due to lower volume.
- Retail unit sales declined by 5.4%, while used unit comps fell by 6.3%.
💡 Before it’s here, it’s on Smartkarma
Sign Up for Free
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
- ✓ Unlimited Research Summaries
- ✓ Personalised Alerts
- ✓ Custom Watchlists
- ✓ Company Data and News
- ✓ Events & Webinars
